“…To promote the use of VMAs in clinical settings, medical and HCI experts and regulatory agencies should work together to identify and adhere to standardised vocabulary, methods for the design [34][35][36] and evaluation 4,13,37 of digital solutions for healthcare. In the longer term, this interdisciplinarity would provide the opportunity to develop VMAs fully compliant with standards and legal aspects, as stated by the International Organization for Standardization (ISO) in the standard for Human-centred design for Interactive systems (ISO 9241-210:2019) 17,38 and by several health regulatory agencies (such as the National Institute for Health and Care Excellence, 39 the National Health Service 40 ; the Medical Research Council, 41 or the European Medicines Agency 42 ). In the academic field, among other evaluation models proposed, [43][44][45] Torous and colleagues 46,47 recently recommended four steps to be met before including new technological tools can in clinical practice: (1) consider risk and privacy issues, (2) validate efficacy for health, (3) ensure engagement, and (4) establish interoperability.…”